| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 173.682 | 386.497 | 555.986 | 625.448 |
| Total Income - EUR | - | - | - | - | - | - | 173.689 | 388.350 | 559.095 | 625.763 |
| Total Expenses - EUR | - | - | - | - | - | - | 137.474 | 276.668 | 518.661 | 602.135 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 36.216 | 111.681 | 40.434 | 23.628 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 31.044 | 102.056 | 35.939 | 19.745 |
| Employees | - | - | - | - | - | - | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Reshapein Hcm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 51.387 | 122.803 | 120.967 | 110.119 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 33.362 | 45.506 | 63.983 | 94.290 |
| Cash | - | - | - | - | - | - | 18.025 | 77.297 | 56.984 | 15.829 |
| Shareholders Funds | - | - | - | - | - | - | 31.105 | 102.129 | 77.110 | 46.165 |
| Social Capital | - | - | - | - | - | - | 61 | 61 | 61 | 60 |
| Debts | - | - | - | - | - | - | 20.283 | 20.674 | 43.957 | 64.545 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Reshapein Hcm S.r.l.